INT76636

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.58
First Reported 1998
Last Reported 2010
Negated 1
Speculated 0
Reported most in Body
Documents 10
Total Number 12
Disease Relevance 11.36
Pain Relevance 0.59

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

MOS (Homo sapiens)
Pain Link Frequency Relevance Heat
Pain 44 99.30 Very High Very High Very High
Inflammation 12 87.44 High High
cytokine 6 86.40 High High
alcohol 3 81.44 Quite High
Potency 3 81.36 Quite High
Neuritis 6 44.52 Quite Low
spinal inflammation 3 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Hiv-narrow Range Search Term 640 99.98 Very High Very High Very High
Mycobacterium Infection 354 99.84 Very High Very High Very High
Cancer 83 99.64 Very High Very High Very High
Pain 41 99.30 Very High Very High Very High
Disease 186 98.56 Very High Very High Very High
Cognitive Disorder 30 96.32 Very High Very High Very High
Ulcers 48 95.96 Very High Very High Very High
Dementia 5 93.88 High High
Acquired Immune Deficiency Syndrome Or Hiv Infection 35 93.52 High High
Pneumocystis Pneumonia 5 93.08 High High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
METHOD: The association between change in impairment (Tsui), and change in pain (TWSTRS-Pain) and functional health (TWSTRS-D, MOS-20) was expressed in percentages of variance explained.
Gene_expression (expressed) of MOS associated with pain
1) Confidence 0.58 Published 1998 Journal Mov. Disord. Section Abstract Doc Link 9686779 Disease Relevance 0.52 Pain Relevance 0.26
any of the instruments reviewed; however, the MOS-HIV was found
Gene_expression (reviewed) of MOS associated with hiv-narrow range search term
2) Confidence 0.58 Published 2003 Journal Health Qual Life Outcomes Section Body Doc Link PMC183842 Disease Relevance 1.94 Pain Relevance 0
to develop the MOS-HIV were included in the instrument to measure
Gene_expression (develop) of MOS associated with hiv-narrow range search term
3) Confidence 0.58 Published 2003 Journal Health Qual Life Outcomes Section Body Doc Link PMC183842 Disease Relevance 2.34 Pain Relevance 0
The SF-36 was developed for the longitudinal phase of the MOS.
Gene_expression (phase) of MOS
4) Confidence 0.58 Published 2003 Journal Health Qual Life Outcomes Section Body Doc Link PMC183842 Disease Relevance 1.07 Pain Relevance 0.16
on using the SF-36 or MOS-HIV in studies of persons with HIV disease

The purpose

Gene_expression (using) of MOS associated with hiv-narrow range search term and disease
5) Confidence 0.58 Published 2003 Journal Health Qual Life Outcomes Section Title Doc Link PMC183842 Disease Relevance 1.74 Pain Relevance 0
Examples of Studies of Persons with HIV using MOS-HIV
Gene_expression (using) of MOS associated with hiv-narrow range search term
6) Confidence 0.58 Published 2003 Journal Health Qual Life Outcomes Section Body Doc Link PMC183842 Disease Relevance 0.58 Pain Relevance 0
However PHC MOs, particularly in urban areas, were often not present at validation and admitted that they had little further knowledge of patients after referring for validation.
Neg (not) Gene_expression (present) of MOs
7) Confidence 0.38 Published 2009 Journal PLoS ONE Section Body Doc Link PMC2791232 Disease Relevance 0.36 Pain Relevance 0
This reduced exposure of the PHC MOs to leprosy patients and reduced their capacity to diagnose leprosy.
Gene_expression (exposure) of MOs associated with mycobacterium infection
8) Confidence 0.33 Published 2009 Journal PLoS ONE Section Body Doc Link PMC2791232 Disease Relevance 0.50 Pain Relevance 0
There were claims that in urban hospitals the MOs or other PHC staff tried to dismiss leprosy patients as quickly as possible to avoid unease amongst other patients, medical staff (including dressers) and the leprosy patients themselves.
Gene_expression (staff) of MOs associated with mycobacterium infection
9) Confidence 0.33 Published 2009 Journal PLoS ONE Section Body Doc Link PMC2791232 Disease Relevance 1.01 Pain Relevance 0
The immune rejection of MSV-induced tumors releases multiple factors influencing bone homeostasis [23].
Gene_expression (rejection) of MSV associated with cancer
10) Confidence 0.05 Published 2010 Journal International Journal of Molecular Sciences Section Body Doc Link PMC2956094 Disease Relevance 0.54 Pain Relevance 0.09
Lesions induced by MSV injection during the preosteogenic stage of bone induction (day 4) had no significant effect on ectopic bone yield, although the mean values of bone induction were lower than those for the contralateral, MSV-unexposed implants.
Gene_expression (injection) of MSV
11) Confidence 0.05 Published 2010 Journal International Journal of Molecular Sciences Section Body Doc Link PMC2956094 Disease Relevance 0.27 Pain Relevance 0.04
The MSV preparation was a saline homogenate of the tumor, grown in a newborn BALB/c mouse following inoculation of MSV.
Gene_expression (preparation) of MSV associated with cancer
12) Confidence 0.05 Published 2010 Journal International Journal of Molecular Sciences Section Body Doc Link PMC2956094 Disease Relevance 0.48 Pain Relevance 0.04

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox